DK1148065T3 - Fusionsproteiner omfattende to oplöselige gp130-molekyler - Google Patents

Fusionsproteiner omfattende to oplöselige gp130-molekyler

Info

Publication number
DK1148065T3
DK1148065T3 DK00108691T DK00108691T DK1148065T3 DK 1148065 T3 DK1148065 T3 DK 1148065T3 DK 00108691 T DK00108691 T DK 00108691T DK 00108691 T DK00108691 T DK 00108691T DK 1148065 T3 DK1148065 T3 DK 1148065T3
Authority
DK
Denmark
Prior art keywords
soluble
sgp130
molecules
fusion proteins
responses
Prior art date
Application number
DK00108691T
Other languages
English (en)
Inventor
Stefan Rose-John
Original Assignee
Conaris Res Inst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conaris Res Inst Ag filed Critical Conaris Res Inst Ag
Application granted granted Critical
Publication of DK1148065T3 publication Critical patent/DK1148065T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK00108691T 2000-04-21 2000-04-21 Fusionsproteiner omfattende to oplöselige gp130-molekyler DK1148065T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00108691A EP1148065B1 (en) 2000-04-21 2000-04-21 Fusion proteins comprising two soluble gp130 molecules

Publications (1)

Publication Number Publication Date
DK1148065T3 true DK1148065T3 (da) 2008-04-28

Family

ID=8168532

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00108691T DK1148065T3 (da) 2000-04-21 2000-04-21 Fusionsproteiner omfattende to oplöselige gp130-molekyler

Country Status (8)

Country Link
EP (1) EP1148065B1 (da)
AT (1) ATE382636T1 (da)
CY (1) CY1107380T1 (da)
DE (1) DE60037648T2 (da)
DK (1) DK1148065T3 (da)
ES (1) ES2298106T3 (da)
PT (1) PT1148065E (da)
SI (1) SI1148065T1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100453877B1 (ko) 2001-07-26 2004-10-20 메덱스젠 주식회사 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
DE10321317A1 (de) * 2003-05-13 2004-12-23 Christian-Albrechts-Universität Zu Kiel Verfahren zum Nachweis des funktionellen IL-6/ sIL-6-Rezeptor-Komplexes und Test-Kit zur Durchführung dieses Verfahrens
EP1491554A1 (en) * 2003-06-23 2004-12-29 CONARIS research institute AG PEGylated soluble gp130-dimers useful as a medicament
PT1630232E (pt) * 2004-08-27 2008-10-02 Conaris Res Inst Ag Sequências de nucleótidos optimizadas que codificam sgp130
EP1801121A1 (en) * 2005-12-23 2007-06-27 CONARIS research institute AG Soluble gp130 molecule variants useful as a medicament
EP1873166B1 (en) * 2006-06-30 2010-09-08 CONARIS research institute AG Improved sgp 130Fc dimers
WO2009109584A1 (en) * 2008-03-07 2009-09-11 Ferring International Center S. A. ANTIBODY BINDING ONLY TO IL6-sIL6R COMPLEX
HUE039412T2 (hu) 2010-11-23 2018-12-28 Glaxo Group Ltd Antigén megkötõ proteinek oncostatin M (OSM) megkötésére
US20170165334A1 (en) * 2015-12-11 2017-06-15 Tianxin Wang Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
JP6775513B2 (ja) * 2014-12-01 2020-10-28 フェリング・ベー・フェー 選択的ｉｌ−６−トランス−シグナル伝達阻害剤の投与
MA41116A (fr) 2014-12-01 2017-10-10 Ferring Bv Compositions d'inhibiteur de trans-signalisation par l'il-6 sélectif
WO2020178193A1 (en) 2019-03-01 2020-09-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Method of treatment of sarcoidosis
KR20230024362A (ko) 2020-06-10 2023-02-20 훼링 비.브이. 죽상경화성 심혈관질환의 치료를 위한 약제학적 화합물
TW202242142A (zh) 2020-12-22 2022-11-01 荷蘭商菲林公司 預測炎性腸病患者的響應之血液基因表現生物標誌物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262522A (en) * 1991-11-22 1993-11-16 Immunex Corporation Receptor for oncostatin M and leukemia inhibitory factor
US5783672A (en) * 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M

Also Published As

Publication number Publication date
ATE382636T1 (de) 2008-01-15
SI1148065T1 (sl) 2008-06-30
EP1148065B1 (en) 2008-01-02
EP1148065A1 (en) 2001-10-24
ES2298106T3 (es) 2008-05-16
PT1148065E (pt) 2008-04-03
CY1107380T1 (el) 2012-12-19
DE60037648D1 (de) 2008-02-14
DE60037648T2 (de) 2010-06-17

Similar Documents

Publication Publication Date Title
CY1107380T1 (el) Πρωτεϊνες συντηξης που περιλαμβανουν δυο διαλυτα gp130 μορια
DK0510079T3 (da) Proteiner, der er produceret af humane lymfocytter, DNA-sekvenser, der koder for disse proteiner, og farmaceutiske og biolo
TR199901361T2 (xx) S�lfonamid t�revleri, haz�rlanma prosesi ve ila� olarak kullan�mlar�
Putnam Abnormal human serum globulins
ES2093623T3 (es) Receptores monovalentes y oligovalentes, bioespecificos y oligoespecificos, su preparacion y empleo.
ATE466932T1 (de) Vermehrung von viren in zellkultur
ATE339505T1 (de) Antagoniste von interleukin-15
NO963018D0 (no) CTLA4-mutantmolekyler og anvendelser derav
BR0013231A (pt) Complexos citocina-anticorpo múltiplos
EP1193438A3 (de) Stativ
EP1403788A3 (en) Eliminating group-by operation in a join plan
DE69529973T2 (de) Superagonisten und Antagonisten von Humanen IL-6 und Methoden zu deren Selektion
DK1724354T3 (da) Cirkulær DNA-molekyle med en afhængig replikationsoprindelse, fremgangsmåde til fremstilling heraf og anvendelse heraf i genterapi
DK0505311T3 (da) Fremstilling til fremstilling af hemproteiner
ATE466930T1 (de) Universelles sammelmedium
MX2007003771A (es) Un sistema para venta de boletos de entrada.
DE69519748D1 (de) Aus den vorstufen des mage tumor-abstossungsantigen abstammende einzelne peptede, die hla-a2 moleküle komplexieren
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
DE69605553T2 (de) Emulator für eine sql relationelle datenbank
CA2385830A1 (en) Probe for protein-protein interaction analysis, and method of using it for analysis of protein-protein interaction
EA200600738A1 (ru) Способ
DK0414019T3 (da) Substituerede N-(quinolin-2-yl-methoxy)benzyl-sulfonylurinstoffer
DE69132346T2 (de) 4-Chlor-1-(ethoxymethyl)-2-(p-chlorophenyl)-5-(trifluoromethyl)pyrrol-3-carbonitril und dessen Verwendung als Insektizid, Nematozid und Acarizid
ES2103595T3 (es) Determinacion de la concentracion de un gas.
DE3888887D1 (de) Monoklonale Antikörper gegen E7-Protein des Humanen Papillomvirus Typ 16, Verfahren zu ihrer Herstellung sowie ihre Verwendung.